Investment in Production Facilities, R&D and Sales Personnel
First written in FY2016. 34 of 41 entries say "Advanced", first in FY2017-Q2. Latest entry: 2026-08-07.
21 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「In addition, the company introduced new equipment and renewed moulds for rationalisation, cost reductions and lower environmental impact, bringing total capital expenditures for the fiscal year to ¥150,254 million, up 39.4% year on year.」
In connection with its investment policy for production facilities, research and development, IT infrastructure and sales personnel, capital expenditures for the fiscal year expanded to ¥150,254 million. Research and development expenses also amounted to ¥39,986 million, indicating increased investment in the foundations for growth. - FY2026-H1AdvancedAnnual report
「Spending on fixed assets amounted to ¥80,722 million, an increase of ¥37,225 million. Total research and development expenses for the six-month interim consolidated accounting period were ¥17,605 million, up 9.3% from the same interim period of the previous year.」
The Company carried out ¥80,722 million in spending on fixed assets, including production facilities, and recorded ¥17,605 million in research and development expenses. Spending on fixed assets increased by ¥37,225 million from the same interim period of the previous year, while research and development expenses rose 9.3%, showing actual investment in the foundations for growth. - FY2025AdvancedAnnual report
「Total capital expenditures for the fiscal year amounted to ¥107,803 million, up 2.2% from the previous fiscal year.」
The Company carried out ¥107,803 million in capital expenditures on production, logistics and research and development sites. Research and development expenses also amounted to ¥33,351 million, up 7.1% from the previous fiscal year, indicating progress in the actual implementation of its investment policy for production facilities, research and development and IT infrastructure. - FY2025-H1AdvancedAnnual report
「Spending on fixed assets amounted to ¥43,497 million, an increase of ¥9,709 million. Total research and development expenses for the six-month interim consolidated accounting period were ¥16,111 million, up 7.3% from the same interim period of the previous year.」
The Company carried out ¥43,497 million in investment in fixed assets, including production facilities, and recorded ¥16,111 million in research and development expenses. Spending on fixed assets increased by ¥9,709 million from the same interim period of the previous year, while research and development expenses rose 7.3%. - FY2024AdvancedAnnual report
「Total capital expenditures for the fiscal year amounted to ¥105,522 million, up 29.3% year on year.」
The Company began construction of a new head office and research and development site, in addition to production and logistics facilities, and carried out ¥105,522 million in capital expenditures. Research and development expenses also amounted to ¥31,141 million, indicating progress in the actual implementation of its investment policy for production facilities, research and development and IT infrastructure. - FY2024-Q3AdvancedAnnual report
「Property, plant and equipment increased by ¥30,221 million, mainly due to capital expenditures at manufacturing sites. Total research and development expenses for the nine-month period ended 31 December were ¥22,982 million, up 14.1% year on year.」
The Company advanced capital expenditures at manufacturing sites, resulting in a ¥30,221 million increase in property, plant and equipment. Research and development expenses also amounted to ¥22,982 million, up 14.1% year on year, indicating progress in investment in production facilities and research and development. - FY2024-Q2AdvancedAnnual report
「The main factor was spending of ¥33,787 million on fixed assets, a decrease of ¥7,968 million in spending.」
The Company carried out ¥33,787 million in investment in fixed assets, including production facilities. Research and development expenses also amounted to ¥15,010 million, up 10.5% year on year, providing figures for investment in production facilities and research and development. - FY2024-Q1AdvancedAnnual report
「Total research and development expenses for the three-month period ended 30 June were ¥7,199 million, up 14.9% year on year. Assets included cash and deposits of ¥565,938 million, down ¥37,632 million, inventories of ¥465,359 million, up ¥46,757 million, and property, plant and equipment of ¥348,325 million, up ¥21,330 million.」
The Company recorded ¥7,199 million in research and development expenses, up 14.9% year on year. Property, plant and equipment also increased by ¥21,330 million, providing figures that show the execution of investment in production facilities and research and development. - FY2023AdvancedAnnual report
「The Company actively proceeded with the construction and expansion of production and logistics sites, acquired land for relocating a research and development site, and introduced new equipment and renewed molds for rationalisation, cost reductions and lower environmental impact. Total capital expenditures for the fiscal year, including intangible fixed assets, amounted to ¥81,592 million, down 2.3% from the previous fiscal year.」
In addition to investment in production and logistics facilities, the Company acquired land for relocating a research and development site and carried out ¥81,592 million in capital expenditures. Research and development expenses also amounted to ¥27,361 million, indicating continued investment in the foundations for growth. - FY2023-Q3AdvancedAnnual report
「Property, plant and equipment amounted to ¥316,870 million, an increase of ¥46,285 million, due mainly to expanded investment in production and logistics facilities in Japan and overseas to secure production capacity in response to higher sales and strengthen business continuity planning to improve the sustainability of product supplies, as well as the acquisition of land for relocating a research and development site to improve research and development capabilities and secure highly skilled personnel. Total research and development expenses for the nine-month period ended 31 December were ¥20,149 million, up 15.6% year on year.」
The Company expanded investment in production and logistics facilities in Japan and overseas, acquired land for relocating a research and development site, and recorded ¥20,149 million in research and development expenses. Investment in production facilities and research and development also advanced in terms of the figures. - FY2023-Q2AdvancedAnnual report
「Total research and development expenses for the six-month period ended 30 September were ¥13,584 million, up 20.8% year on year.」
The Company continued capital expenditures aimed at expanding production capacity, while research and development expenses rose to ¥13,584 million, up 20.8% year on year. The figure shows the execution of investment in production facilities and research and development. - FY2023-Q1AdvancedAnnual report
「Property, plant and equipment amounted to ¥298,886 million, an increase of ¥28,301 million, mainly because the Company expanded investment in production and logistics facilities in Japan and overseas to secure production capacity in response to higher sales and strengthen business continuity planning to improve the sustainability of product supplies. The Company also acquired land to rebuild the Tsukuba Technical Center, the Group's core research and development site, which is becoming outdated, mainly to improve its research and development capabilities and secure highly skilled development personnel. Total research and development expenses for the three-month period ended 30 June were ¥6,265 million, up 14.1% year on year.」
Investment in production and logistics facilities was expanded, land was acquired for rebuilding the Tsukuba Technical Center, and ¥6,265 million in research and development expenses was recorded. The execution of investment in production facilities and research and development advanced. - FY2022AdvancedAnnual report
「Total capital expenditures for the fiscal year, including intangible fixed assets such as leasehold rights, amounted to ¥83,499 million, up 204.3% from the previous fiscal year.」
The Company invested ¥83,499 million in production and logistics facilities and other assets, while research and development expenses rose to ¥23,457 million, up 12.4% from the previous fiscal year. The Company's investment policy for production facilities, research and development, IT infrastructure and sales personnel advanced in terms of actual results. - FY2022-Q3AdvancedAnnual report
「Total research and development expenses for the nine-month period ended 31 December were ¥17,422 million, up 13.3% year on year.」
The Company invested ¥17,422 million in research and development, up 13.3% year on year. The figure shows investment in the foundations for growth, alongside investment in production facilities. - FY2022-Q2AdvancedAnnual report
「Cash used in investing activities amounted to ¥63,162 million, compared with cash provided of ¥2,887 million in the same period of the previous year, representing an increase of ¥66,049 million in spending. The main year-on-year factors reducing cash were a ¥29,692 million increase in net spending on deposits and withdrawals of time deposits and a ¥38,679 million increase in spending on the acquisition of property, plant and equipment. Total research and development expenses for the six-month period ended 30 September were ¥11,241 million, up 10.4% year on year.」
Spending on the acquisition of property, plant and equipment increased by ¥38,679 million year on year, while research and development expenses rose to ¥11,241 million, up 10.4% year on year. Specific figures show the execution of investment in production facilities and research and development. - FY2022-Q1AdvancedAnnual report
「The Company used cash and deposits, which had increased with the rise in retained earnings, for active capital expenditures and the acquisition of land for construction of a new head office, resulting in an increase in property, plant and equipment. Total research and development expenses for the three-month period ended 30 June were ¥5,492 million, up 11.0% year on year.」
The Company used cash and deposits for active capital expenditures and the acquisition of land for a new head office, while research and development expenses rose to ¥5,492 million, up 11.0% year on year. The figures show the execution of capital expenditures and research and development investment. - FY2021Decrease in capital expenditures and research and development expensesAnnual report
「Total capital expenditures for the fiscal year, including intangible fixed assets such as leasehold rights, amounted to ¥27,439 million, down 28.5% from the previous fiscal year.」
Investment in production facilities decreased 28.5% from the previous fiscal year due to delays caused by an infectious disease, while research and development expenses also declined 2.8% to ¥20,874 million. The Company explained that there had been no material changes in its research and development activities. - FY2021-Q3Year-on-year decrease in research and development expenses (third quarter)Annual report
「Total research and development expenses for the nine-month period ended 31 December were ¥15,381 million, down 6.0% year on year.」
While stating that there had been no material changes in research and development activities, the Company reported research and development expenses of ¥15,381 million for the nine-month cumulative period, down 6.0% year on year. - FY2021-Q2Year-on-year decrease in research and development expenses (second quarter)Annual report
「Total research and development expenses for the six-month period ended 30 September were ¥10,181 million, down 6.8% year on year.」
While explaining that there had been no material changes in research and development activities, the Company reported research and development expenses of ¥10,181 million for the six-month cumulative period ended 30 September, down 6.8% year on year. - FY2021-Q1Year-on-year decrease in research and development expensesAnnual report
「Total research and development expenses for the three-month period ended 30 June were ¥4,946 million, down 7.0% year on year.」
While stating that there had been no material changes in research and development activities, the Company reported research and development expenses of ¥4,946 million for the three-month cumulative period ended 30 June, down 7.0% year on year. - FY2020AdvancedAnnual report
「Total capital expenditures for the fiscal year, including intangible fixed assets such as leasehold rights, amounted to ¥38,370 million, up 20.1% from the previous fiscal year. Research and development expenses for the fiscal year were ¥21,480 million, up 0.5% from the previous fiscal year.」
The Company carried out ¥38,370 million in investment in production facilities and recorded ¥21,480 million in research and development expenses. Capital expenditures rose 20.1% from the previous fiscal year, while research and development expenses increased 0.5%. - FY2020-Q3AdvancedAnnual report
「Total research and development expenses for the nine-month period ended 31 December were ¥16,365 million, up 3.2% year on year.」
Research and development expenses for the nine-month cumulative period amounted to ¥16,365 million, up 3.2% year on year. Additional figures show the amount of research and development investment executed. - FY2020-Q2AdvancedAnnual report
「Total research and development expenses for the six-month period ended 30 September were ¥10,928 million, up 4.4% year on year.」
Research and development expenses for the six-month cumulative period ended 30 September amounted to ¥10,928 million, up 4.4% year on year. The Company also spent ¥20,553 million on the acquisition of property, plant and equipment, continuing to invest in production facilities and research and development. - FY2020-Q1AdvancedAnnual report
「Total research and development expenses for the three-month period ended 30 June were ¥5,319 million, up 2.8% year on year.」
During the three-month cumulative period ended 30 June, the Company recorded ¥5,319 million in research and development expenses, up 2.8% year on year. The specific amount of research and development investment executed was provided. - FY2019AdvancedAnnual report
「Total capital expenditures for the fiscal year, including intangible fixed assets such as leasehold rights, amounted to ¥31,936 million, up 34.8% from the previous fiscal year. Research and development expenses for the fiscal year were ¥21,367 million, up 5.6% from the previous fiscal year.」
The Company carried out ¥31,936 million in investment in production facilities and recorded ¥21,367 million in research and development expenses, both up from the previous fiscal year. - FY2019-Q3AdvancedAnnual report
「Total research and development expenses for the nine-month period ended 31 December were ¥15,865 million, up 5.7% year on year.」
During the nine-month cumulative period ended 31 December, the Company recorded ¥15,865 million in research and development expenses, up 5.7% year on year. Additional figures show the amount of research and development investment executed. - FY2019-Q2AdvancedAnnual report
「Cash used in investing activities amounted to ¥37,452 million, a decrease of ¥23,377 million in spending from the same period of the previous year. The main factors were net spending of ¥16,844 million on deposits and withdrawals of time deposits and spending of ¥16,298 million on the acquisition of property, plant and equipment. Total research and development expenses for the six-month period ended 30 September were ¥10,472 million, up 3.7% year on year.」
During the six-month cumulative period ended 30 September, the Company spent ¥16,298 million on the acquisition of property, plant and equipment and recorded ¥10,472 million in research and development expenses. The figures provide specific evidence of investment in production facilities and research and development. - FY2019-Q1AdvancedAnnual report
「Total research and development expenses for the three-month period ended 30 June were ¥5,172 million, up 5.0% year on year.」
The Company spent ¥5,172 million on research and development, up 5.0% year on year. The quarterly figure shows the execution of research and development investment. - FY2018AdvancedAnnual report
「The Group is actively proceeding with the construction and expansion of factories and the acquisition of factory sites in Japan and overseas, with the aim of establishing an optimal global production structure for the future. It also introduced new equipment and renewed molds to achieve further rationalisation and cost reductions. Total capital expenditures for the fiscal year, including intangible fixed assets such as leasehold rights, amounted to ¥23,683 million, up 9.3% from the previous fiscal year. Research and development expenses for the fiscal year were ¥20,239 million, up 5.9% from the previous fiscal year.」
The Company carried out ¥23,683 million in investment in production facilities and recorded ¥20,239 million in research and development expenses, both up from the previous fiscal year. Specific figures were provided for investment in the production structure, research and development, and rationalisation. - FY2018-Q3AdvancedAnnual report
「Total research and development expenses for the nine-month period ended 31 December were ¥15,009 million, up 5.5% year on year.」
Research and development expenses for the nine-month cumulative period ended 31 December amounted to ¥15,009 million, up 5.5% year on year. Additional figures show the progress of research and development investment. - FY2018-Q2AdvancedAnnual report
「Total research and development expenses for the six-month period ended 30 September were ¥10,100 million, up 6.0% year on year.」
Research and development expenses for the six-month cumulative period ended 30 September were ¥10,100 million, up 6.0% year on year. Additional figures show the progress of research and development investment. - FY2018-Q2AdvancedAnnual report
「Payments for the acquisition of property, plant and equipment: ¥13,873 million.」
During the six-month cumulative period ended 30 September, the Company spent ¥13,873 million on the acquisition of property, plant and equipment. The figure provides specific evidence of investment in production facilities and other assets. - FY2018-Q1AdvancedAnnual report
「Total research and development expenses for the three-month period ended 30 June were ¥4,926 million, up 1.9% year on year.」
Research and development expenses for the three-month cumulative period ended 30 June were ¥4,926 million, up 1.9% year on year. The quarterly figure shows the progress of research and development investment. - FY2017AdvancedAnnual report
「The Group's basic strategy is to concentrate its investment in the industrial automation equipment business, its core business and one with expected future growth. During the fiscal year, the Group invested ¥21,663 million in capital expenditures, down 14.5% from the previous fiscal year. The planned investment in new facilities, upgrades and other projects for the next fiscal year was ¥35,500 million as of the end of the fiscal year, all of which is expected to be financed with internal funds.」
The Company continued to concentrate investment in its core business, carrying out ¥21,663 million in capital expenditures during the fiscal year. It plans capital expenditures of ¥35,500 million in the next fiscal year, to be financed entirely with internal funds. - FY2017-Q3AdvancedAnnual report
「Total research and development expenses for the nine-month period ended 31 December were ¥14,230 million, up 2.4% year on year.」
Research and development expenses for the nine-month cumulative period amounted to ¥14,230 million, up 2.4% year on year. Additional figures show the progress of research and development investment. - FY2017-Q2AdvancedAnnual report
「Payments for the acquisition of property, plant and equipment: ¥8,703 million Total research and development expenses for the six-month period ended 30 September were ¥9,532 million, up 1.8% year on year.」
During the six-month cumulative period ended 30 September, the Company spent ¥8,703 million on the acquisition of property, plant and equipment and recorded ¥9,532 million in research and development expenses. The figures provide specific evidence of investment in production facilities and research and development. - FY2016First statedAnnual report
「The Company is actively investing to enhance and strengthen its production facilities, research and development, sales personnel and other resources necessary to maintain its competitive advantage over the long term and remain a going concern, while securing sufficient cash on hand to meet the resulting funding needs.」
The Company indicated that it intends to use retained earnings and cash on hand to strengthen its production structure, research and development, sales personnel and other areas.